CC
REGN icon

Codex Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Codex Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$5.53M Hold
5,750
– – 2.7% 15
2023
Q4 		$5.05M Sell
5,750
-450
-7% -$371K 2.95% 16
2023
Q3 		$5.1M Buy
6,200
+1,000
+19% +$786K 3.29% 14
2023
Q2 		$3.74M Sell
5,200
-340
-6% -$262K 2.41% 18
2023
Q1 		$4.55M Hold
5,540
– – 3.14% 17
2022
Q4 		$4M Hold
5,540
– – 3.34% 15
2022
Q3 		$3.82M Buy
+5,540
New +$3.49M 3.27% 14

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Codex Capital's REGN Position: Q1 2024 in Review

Codex Capital held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2024 at 5,750 shares worth $5.53M. The position accounts for 2.7% of the portfolio, ranked #15.

Codex Capital first reported a position in REGN in Q3 2022 and has held it in 7 quarters since. 1,309 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

  • Codex Capital held 5,750 shares of Regeneron Pharmaceuticals worth $5.53M as of Q1 2024.
  • Codex Capital left its Regeneron Pharmaceuticals share count unchanged in Q1 2024.
  • Regeneron Pharmaceuticals made up 2.7% of Codex Capital's portfolio in Q1 2024, its #15 holding.
  • Codex Capital first reported a position in Regeneron Pharmaceuticals in Q3 2022 and has held it in 7 quarters since.
  • 1,309 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Codex Capital's 13F filing for Q1 2024, filed 7 May 2024.